Komori
OPTiM (3694) · RiskRestated

Third-Party Patents, Patent Infringement and Commoditization Risk

First written in FY2016. 5 of 6 entries say "Restated". Latest entry: FY2024.

6entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY20242016: 120162017: 020172018: 120182019: 120192020: 020202021: 120212022: 120222023: 020232024: 12024
Same theme, other companies
Third-Party and Own Intellectual Property Rights Infringement RiskA theme 365 companies write about · 366 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2025: 9 of 59 companies on the "Worse" side.

127 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 366 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2024RestatedAnnual report

    「If a third party obtains a patent in the Group's business areas, this may hinder the Group's business development and affect its business results. Conversely, if the Group's patents are infringed by a third party, this may affect the Group's business results. In addition, the Group's services may become commoditised after the patents expire.」

    The risks of third-party patents, infringement of its own patents, and commoditisation after patent expiry remain.
  2. FY2022RestatedAnnual report

    「If a third party obtains a patent in the Group's business areas, this may hinder the Group's business development and affect its business results. Conversely, if the Group's patents are infringed by a third party, this may affect the Group's business results.」

    The Company continues to disclose the risks of third-party patents, infringement of its own patents, and commoditisation after patent expiry.
  3. FY2021RestatedAnnual report

    「If a third party obtains a patent in the Group's business areas, this may hinder the Group's business development and affect its business results. Conversely, if the Group's patents are infringed by a third party, this may affect the Group's business results.」

    The Company continues to disclose the risks of third-party patents, infringement of its own patents, and commoditisation after patent expiry.
  4. FY2019RestatedAnnual report

    「If a third party obtains a patent in the Company's business areas, this may hinder the Company's business development and affect its business results. Conversely, if the Company's patents are infringed by a third party, this may affect the Company's business results. In addition, the Company's services may become commoditised after the patents expire.」

    The risks of third-party patents, infringement of its own patents, and commoditisation after patent expiry remain.
  5. FY2018RestatedAnnual report

    「If a third party obtains a patent in the Company's business areas, this may hinder the Company's business development and affect its business results. Conversely, if the Company's patents are infringed by a third party, this may affect the Company's business results. In addition, the Company's services may become commoditised after the patents expire.」

    The Company continues to disclose the risks of third-party patents, infringement of its own patents, and commoditisation after patent expiry.
  6. FY2016First statedAnnual report

    「If a third party obtains a patent in the Company's business areas, this may hinder the Company's business development and affect its business results. Conversely, if the Company's patents are infringed by a third party, this may affect the Company's business results. In addition, the Company's services may become commoditised after the patents expire.」

    While positioning ownership of its own patents as the basis for differentiation, the Company discloses the risks of third-party rights, infringement of its own rights, and commoditisation after patent expiry.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for OPTiM yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.